Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Graves' disease

Recruiting

Investigational

Study of IMVT-1402 Treatment for Adults with Graves' Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

Breast cancer+2

Recruiting

Registered drugNo placebo

Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Breast cancer+1

Recruiting

Registered drugNo placebo

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Coronary artery disease+1

Recruiting

Registered drugNo placebo

Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Transitional cell cancer of the renal pelvis and ureter

Recruiting

InvestigationalNo placebo

Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Mitomycin

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:RO7837195

Contact Research Centre

Chronic lymphocytic leukaemia refractory+13

Recruiting

Registered drugNo placebo

Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:BGB-16673

Contact Research Centre

Cardiac failure chronic+1

Recruiting

Registered drugNo placebo

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Ferric Derisomaltose

Contact Research Centre

Heart failure with reduced ejection fraction

Recruiting

Investigational

Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:OMECAMTIV MECARBIL

Contact Research Centre

Hypertension

Recruiting

Registered drug

Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Amlodipine

Contact Research Centre

Colorectal cancer

Recruiting

Registered drugNo placebo

Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Amivantamab

Contact Research Centre

Find therapies in clinical trials near you – page 5

142 trials match your criteria

Graves' disease

Study of IMVT-1402 Treatment for Adults with Graves' Disease

Breast cancer+2

Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Breast cancer+1

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Coronary artery disease+1

Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

Triple negative breast cancer

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Transitional cell cancer of the renal pelvis and ureter

Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

Colitis ulcerative

Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

Chronic lymphocytic leukaemia refractory+13

Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

Cardiac failure chronic+1

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Heart failure with reduced ejection fraction

Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

Hypertension

Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

Colorectal cancer

Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.